Endoscopic balloon dilatation for benign esophageal stricture after endoscopic submucosal dissection for early esophageal neoplasms

Lian, Jing; Li, Li; Hu, Jian; Chen, Shi Yao; Wen, Qin; Xu, Mei Dong; Zhou, Ping; Yao, Li

doi:10.1111/1751-2980.12136

Cited by 22 publications

(16 citation statements)

References 17 publications

(26 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…reported that post‐ESD esophageal strictures could be successfully managed by temporary dilation with a median of two sessions. In addition, dilation with bougie and balloon is reported to be safe and effective for managing benign esophageal strictures . Temporary stent insertions have also been increasingly used for the disease .…”

Section: Discussionmentioning

confidence: 99%

“…In addition, dilation with bougie and balloon is reported to be safe and effective for managing benign esophageal strictures. 21 Temporary stent insertions have also been increasingly used for the disease. 22 However, it is not the first choice of treatment considering the inflammatory hyperplasia that occurs with partially covered metal stents and a high migration rate with the fully covered metal stents.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Intramuscular injection of mitomycin C combined with endoscopic dilation for benign esophageal strictures

Zhang

Wang

Liu

et al. 2015

J of Digest Diseases

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Intramuscular injection of mitomycin C combined with endoscopic dilation for benign esophageal strictures

Zhang

Wang

Liu

et al. 2015

J of Digest Diseases

View full text Add to dashboard Cite

show abstract

“…[20][21][22] This may lead to greater reluctance in elderly patients and their relatives to grant consent for ESD interventions. In addition, although a significantly higher percentage of patients received anticoagulant drugs in group A than in group B, no elderly patients in either group developed delayed bleeding.…”

Section: Elderly Patients N=130mentioning

confidence: 99%

Efficacy and safety of endoscopic submucosal dissection for elderly patients with superficial squamous esophageal neoplasms

Peng

Shen

et al. 2016

UEG Journal

View full text Add to dashboard Cite

Background: Little is known about the outcomes of endoscopic submucosal dissection in elderly patients with superficial squamous esophageal neoplasms. Objective: To assess the efficacy and safety of endoscopic submucosal dissection for superficial squamous esophageal neoplasms in elderly patients (!65 years) compared with non-elderly patients. Methods: All patients with superficial squamous esophageal neoplasms receiving endoscopic submucosal dissection were retrospectively analyzed. Among them, 130 were aged 65 or older (group A), and 201 were aged younger than 65 years (group B). Therapeutic efficacy, adverse events, and follow-up data were evaluated. Results: Group A had a higher prevalence of concomitant diseases than group B (52.3% vs. 14.9%, respectively). R0 resection rate was 82.3% in group A and 84.6 % in group B (P ¼ 0.717). The curative resection rate was 80.8% in group A and 83.6% in group B (P ¼ 0.653). The rate of procedure-related non-cardiopulmonary adverse events was 20.8% in group A and 16.9% in group B (P ¼ 0.377). The incidence of cardiopulmonary adverse events during or after the procedure was 6.2% in group A and 2.5% in group B (P ¼ 0.094). No procedure-related mortality was reported in either group. Conclusion: Endoscopic submucosal dissection is effective and safe for treating superficial squamous esophageal neoplasms in elderly patients.

show abstract

“…Endoscopic esophageal dilation is a common method for the prevention and treatment of post-ESD stricture; it includes balloon dilation and bougie dilation, which exhibit different modes of action. Lian et al [14] conducted a retrospective study in which 335 patients with early esophageal cancer received ESD. Among…”

Section: Endoscopic Esophageal Dilationmentioning

confidence: 99%

“…Lian et al . [ 14 ] conducted a retrospective study in which 335 patients with early esophageal cancer received ESD. Among them, 29 patients exhibited varying degrees of dysphagia 17–45 days after ESD and received endoscopic balloon dilation (EBD) 117 times in total.…”

Section: Esophageal Dilationmentioning

confidence: 99%

Advances in the prevention and treatment of esophageal stricture after endoscopic submucosal dissection of early esophageal cancer

Zhang

Wang

et al. 2020

Journal of Translational Internal Medicine

View full text Add to dashboard Cite

Endoscopic submucosal dissection (ESD) has become the main treatment for early esophageal cancer. While treating the disease, ESD may also cause postoperative esophageal stricture, which is a global issue that needs resolution. Various methods have been applied to resolve the problem, such as mechanical dilatation, glucocorticoids, anti-scarring drugs, and regenerative medicine; however, no standard treatment regimen exists. This article describes and evaluates the strengths and limitations of new and promising potential strategies for the treatment and prevention of esophageal strictures.

show abstract

Endoscopic balloon dilatation for benign esophageal stricture after endoscopic submucosal dissection for early esophageal neoplasms

Abstract: EBD is a safe and effective modality for the treatment of benign esophageal stricture after ESD for early esophageal neoplasms.

Cited by 22 publications

References 17 publications

Intramuscular injection of mitomycin C combined with endoscopic dilation for benign esophageal strictures

Intramuscular injection of mitomycin C combined with endoscopic dilation for benign esophageal strictures

Efficacy and safety of endoscopic submucosal dissection for elderly patients with superficial squamous esophageal neoplasms

Advances in the prevention and treatment of esophageal stricture after endoscopic submucosal dissection of early esophageal cancer

Contact Info

Product

Resources

About